Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP913921.RAe_O98get06E9fuOuQH_x3dP62hkXsqreZLj48RI3ExI130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913921.RAe_O98get06E9fuOuQH_x3dP62hkXsqreZLj48RI3ExI130_provenance.
• NP606133.RARv-4Kg4QY4JW8W3XUwgRr7cgZEFR7QlzAgGsjyKApIU130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606133.RARv-4Kg4QY4JW8W3XUwgRr7cgZEFR7QlzAgGsjyKApIU130_provenance.
• assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP978644.RACS4E4IzLXhobKAYL58-_cnJGNZ-eHIvbxdw3pVjr9ec130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978644.RACS4E4IzLXhobKAYL58-_cnJGNZ-eHIvbxdw3pVjr9ec130_provenance.
• NP641131.RAYNWh-w-1Z5WHokNsM_vg3-D2UJ0JcgWnUF67g0rWWm8130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641131.RAYNWh-w-1Z5WHokNsM_vg3-D2UJ0JcgWnUF67g0rWWm8130_provenance.
• NP781556.RAAp27BqtFDoSG9-n9S5lCMOJnyzagoBqyF7hROaBEF4U130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781556.RAAp27BqtFDoSG9-n9S5lCMOJnyzagoBqyF7hROaBEF4U130_provenance.
• assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP873094.RAhpOLvfHZd-5uEaVS8nuTBdxpqqK2fut-XN3F4VUMXqg130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873094.RAhpOLvfHZd-5uEaVS8nuTBdxpqqK2fut-XN3F4VUMXqg130_provenance.
• NP914176.RAsO1HVVG7AO17fQFX0NgAPuECLNBFoWQg-RLZ11zio3c130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914176.RAsO1HVVG7AO17fQFX0NgAPuECLNBFoWQg-RLZ11zio3c130_provenance.
• NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641121.RAmrKa_klTf_RPKasINHk_1IZTOAbJQ1HgxY-hLyXN7Pk130_provenance.
• NP641130.RAr-APzMeQqTiIhE-hNC_y94WAtLQC2M5sOKgJLzsTbCI130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641130.RAr-APzMeQqTiIhE-hNC_y94WAtLQC2M5sOKgJLzsTbCI130_provenance.
• NP641133.RAq3NGShW8I0Ird9HQX5aTP6HwUaZKZQUFp7qoECyOYYk130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641133.RAq3NGShW8I0Ird9HQX5aTP6HwUaZKZQUFp7qoECyOYYk130_provenance.
• NP641135.RAk5LhOsi4iDdQLbwttcoyZGFy7Lk2IvJN0MciymLPTEw130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641135.RAk5LhOsi4iDdQLbwttcoyZGFy7Lk2IvJN0MciymLPTEw130_provenance.
• NP605891.RAKPqL257ILmjc0jRUMKzw-Vfk7flAwrre408enDCm3YQ130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605891.RAKPqL257ILmjc0jRUMKzw-Vfk7flAwrre408enDCm3YQ130_provenance.
• NP781343.RA86MolaxBmjMA4o62aqxf_FRSy7yvSKsvB9kdqy9A18c130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781343.RA86MolaxBmjMA4o62aqxf_FRSy7yvSKsvB9kdqy9A18c130_provenance.
• NP978436.RA1tdTM7AICFc34XcoK8iCNasjxhczGd-lQHLWQhzGT4k130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978436.RA1tdTM7AICFc34XcoK8iCNasjxhczGd-lQHLWQhzGT4k130_provenance.
• NP641120.RA4fxc20k6g7Kea0vKKJOgILXO2wJzhCe9hYYwtZ87VSA130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641120.RA4fxc20k6g7Kea0vKKJOgILXO2wJzhCe9hYYwtZ87VSA130_provenance.
• NP641126.RA9rwrd5vreo_h9NiJutg-BpNYM_FigT4OJvbp_tEDXC0130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641126.RA9rwrd5vreo_h9NiJutg-BpNYM_FigT4OJvbp_tEDXC0130_provenance.
• NP641129.RA1VnKIg1aMIkIuT1E9QXl-P5KCzv4o-rjBL1Z4_HSoSM130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641129.RA1VnKIg1aMIkIuT1E9QXl-P5KCzv4o-rjBL1Z4_HSoSM130_provenance.
• NP641132.RA6tdoWdcOq89fFct62G38G6y_amHGzpHF6LrI6ohD9_w130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641132.RA6tdoWdcOq89fFct62G38G6y_amHGzpHF6LrI6ohD9_w130_provenance.
• NP641134.RA5MxqDZxTbx_NlSrbmXd2dIO287nWZwjFkJPNoae3N4A130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641134.RA5MxqDZxTbx_NlSrbmXd2dIO287nWZwjFkJPNoae3N4A130_provenance.
• NP873294.RA7izSsIxx6fmquESK_O1GT-XoLtl65al2NzZs6WQLl0E130_assertion description "[Class I and Class II mutations are significantly associated, indicating their cooperation in leukemogenesis The chromosome aberrations and gene mutations detected in the therapy-related and in the de novo subsets of MDS and AML are identical, although the frequencies with which they are observed may differ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873294.RA7izSsIxx6fmquESK_O1GT-XoLtl65al2NzZs6WQLl0E130_provenance.